AVITA Medical Inc [NASDAQ: RCEL] price surged by 48.25 percent to reach at $2.2.
A sum of 19546981 shares traded at recent session while its average daily volume was at 335.55K shares. AVITA Medical Inc shares reached a high of $7.12 and dropped to a low of $5.51 until finishing in the latest session at $6.76.
The one-year RCEL stock forecast points to a potential upside of 27.78. The average equity rating for RCEL stock is currently 2.38, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on AVITA Medical Inc [RCEL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RCEL shares is $9.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RCEL stock is a recommendation set at 2.38. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for AVITA Medical Inc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on August 08, 2025. While these analysts kept the previous recommendation, D. Boral Capital raised their target price to Buy. The new note on the price target was released on December 24, 2024, representing the official price target for AVITA Medical Inc stock.
RCEL Stock Performance Analysis:
AVITA Medical Inc [RCEL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 60.57. With this latest performance, RCEL shares gained by 16.55% in over the last four-week period, additionally sinking by -20.94% over the last 6 months – not to mention a drop of -47.19% in the past year of trading.
Insight into AVITA Medical Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and AVITA Medical Inc [RCEL] shares currently have an operating margin of -62.41% and a Gross Margin at 84.28%. AVITA Medical Inc’s Net Margin is presently recorded at -68.87%.
AVITA Medical Inc (RCEL) Capital Structure & Debt Analysis
AVITA Medical Inc (RCEL) Efficiency & Liquidity Metrics
AVITA Medical Inc (RCEL) Efficiency & Liquidity Metrics
From an operational efficiency perspective, AVITA Medical Inc. (RCEL) effectively leverages its workforce, generating an average of -$198346.15 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.58% and a Quick Ratio of 0.46%, indicating strong ability to cover short-term liabilities.
RCEL Stock EPS
With the latest financial reports released by the company, AVITA Medical Inc posted -0.93/share EPS, while the average EPS was predicted by analysts to be reported at -0.69/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.24. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RCEL.
AVITA Medical Inc [RCEL] Institutonal Ownership Details
There are presently around $29.13%, or 29.40%% of RCEL stock, in the hands of institutional investors. The top three institutional holders of RCEL stocks are: BLACKROCK INC. with ownership of 1.78 million shares, which is approximately 7.0222%. VANGUARD GROUP INC, holding 1.4 million shares of the stock with an approximate value of $$11.05 million in RCEL stocks shares; and VANGUARD GROUP INC, currently with $$4.64 million in RCEL stock with ownership which is approximately 2.3072%.
